Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Healthcare Sector Analysis

UpdatedNov 07, 2025
DataAggregated Company Financials
Companies154
  • 7D-4.0%
  • 3M-3.5%
  • 1Y-3.7%
  • YTD-5.0%

Over the last 7 days, the Healthcare industry has dropped 4.0%, driven by declines in Camurus and Medicover of 11% and 9.4%, respectively. In contrast, Asker Healthcare Group has gained 8.4%. The industry has fallen 3.7% in the last year. Earnings are forecast to grow by 30% annually.

Sector Valuation and Performance

Has the Swedish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 07 Nov 2025SEK 588.5bSEK 229.2bSEK 2.8b45.4x212.8x2.6x
Sun, 05 Oct 2025SEK 614.1bSEK 227.1bSEK 6.6b43.2x93x2.7x
Tue, 02 Sep 2025SEK 623.8bSEK 227.1bSEK 6.6b46.1x94.7x2.7x
Thu, 31 Jul 2025SEK 632.0bSEK 226.9bSEK 6.5b54.1x96.6x2.8x
Sat, 28 Jun 2025SEK 616.8bSEK 226.8bSEK 5.9b44.9x105.1x2.7x
Mon, 26 May 2025SEK 587.3bSEK 226.0bSEK 6.6b37x89.3x2.6x
Wed, 23 Apr 2025SEK 549.9bSEK 222.1bSEK 5.0b37.5x110.7x2.5x
Fri, 21 Mar 2025SEK 558.9bSEK 206.3bSEK 5.0b37x112x2.7x
Sun, 16 Feb 2025SEK 594.9bSEK 206.4bSEK 2.5b41.7x236.5x2.9x
Tue, 14 Jan 2025SEK 571.2bSEK 201.6b-SEK 2,648,325,362.5039.2x-215.7x2.8x
Thu, 12 Dec 2024SEK 575.6bSEK 202.8b-SEK 2,465,020,947.5338.6x-233.5x2.8x
Sat, 09 Nov 2024SEK 528.5bSEK 200.2b-SEK 2,597,706,631.9538.6x-203.4x2.6x
Mon, 07 Oct 2024SEK 607.5bSEK 200.2b-SEK 2,782,910,611.7639.8x-218.3x3x
Wed, 04 Sep 2024SEK 607.0bSEK 200.0b-SEK 2,809,391,402.8740x-216.1x3x
Fri, 02 Aug 2024SEK 584.7bSEK 199.7b-SEK 2,762,785,972.7841.1x-211.6x2.9x
Sun, 30 Jun 2024SEK 562.0bSEK 195.7b-SEK 3,202,643,667.9236.8x-175.5x2.9x
Tue, 28 May 2024SEK 552.0bSEK 196.0b-SEK 2,798,220,083.8936.2x-197.3x2.8x
Thu, 25 Apr 2024SEK 521.0bSEK 194.1b-SEK 3,331,281,004.7543.9x-156.4x2.7x
Sat, 23 Mar 2024SEK 519.8bSEK 192.7b-SEK 3,669,066,937.9843.3x-141.7x2.7x
Mon, 19 Feb 2024SEK 516.9bSEK 191.7b-SEK 4,080,444,504.7249.9x-126.7x2.7x
Wed, 17 Jan 2024SEK 551.4bSEK 191.7b-SEK 967,683,823.0048.2x-569.8x2.9x
Fri, 15 Dec 2023SEK 517.8bSEK 191.2b-SEK 999,563,618.0048.9x-518x2.7x
Sun, 12 Nov 2023SEK 470.7bSEK 190.4b-SEK 1,080,492,686.0049.4x-435.7x2.5x
Tue, 10 Oct 2023SEK 439.1bSEK 185.1b-SEK 2,032,014,505.0033.8x-216.1x2.4x
Thu, 07 Sep 2023SEK 457.1bSEK 185.8b-SEK 2,013,608,879.0035.8x-227x2.5x
Sat, 05 Aug 2023SEK 473.1bSEK 183.9b-SEK 1,003,843,769.0039.9x-471.3x2.6x
Mon, 03 Jul 2023SEK 480.3bSEK 179.2b-SEK 793,306,793.0044.7x-605.5x2.7x
Wed, 31 May 2023SEK 504.9bSEK 178.9b-SEK 549,905,700.0043.5x-918.2x2.8x
Fri, 28 Apr 2023SEK 513.3bSEK 174.8b-SEK 1,487,139,903.0035.1x-345.1x2.9x
Sun, 26 Mar 2023SEK 482.3bSEK 172.4b-SEK 1,417,086,752.0035.3x-340.4x2.8x
Tue, 21 Feb 2023SEK 505.5bSEK 169.8b-SEK 615,986,485.0038.8x-820.7x3x
Thu, 19 Jan 2023SEK 520.5bSEK 165.7bSEK 670.8m33.6x775.9x3.1x
Sat, 17 Dec 2022SEK 473.1bSEK 165.3bSEK 708.2m32.1x668x2.9x
Mon, 14 Nov 2022SEK 495.3bSEK 163.3bSEK 949.6m31.3x521.6x3x
Price to Earnings Ratio

521.6x


Total Market Cap: SEK 495.3bTotal Earnings: SEK 949.6mTotal Revenue: SEK 163.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Sector Price to Earnings3Y Average -124.5x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 213x which is higher than its 3-year average PE of -124x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 43% per year over the last three years.
  • Revenues for these companies have grown 12% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare sector?

SE Market-2.32%
Healthcare-4.03%
Medical Equipment-1.39%
Biotech-2.91%
Healthtech-4.70%
Healthcare Services-6.90%
Pharma-9.03%
Life Sciences-9.47%
Industry PE
  • Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 134x.
    • Analysts are expecting annual earnings growth of 19.7%, which is lower than the prior year's growth of 29.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 44% over the next 5 years.
  • However this is lower than its past earnings growth rate of 112% per year.
  • In contrast, the Healthtech industry is expected to see its earnings grow by 20% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ASKER Asker Healthcare GroupSEK 91.228.4%
+SEK 2.7b		n/aPE81.1x
ADDV A ADDvise GroupSEK 2.4819.2%
+SEK 242.4m		-80.0%PE349.5x
IMP A SDB ImplanticaSEK 53.401.5%
+SEK 226.6m		44.3%PS689.4x
MOB Moberg PharmaSEK 10.6035.5%
+SEK 130.7m		-32.1%PS40.4x
SANION SanionaSEK 15.726.2%
+SEK 127.0m		424.0%PE10.1x

Latest News

ASKER
SEK 91.22
Asker Healthcare Group
7D
8.4%
1Y
n/a
MOB
SEK 10.60
Moberg Pharma
7D
35.5%
1Y
-32.1%

We're Not Worried About Moberg Pharma's (STO:MOB) Cash Burn

Nov 07
We're Not Worried About Moberg Pharma's (STO:MOB) Cash Burn
SANION
SEK 15.72
Saniona
7D
6.2%
1Y
424.0%
FLUO
SEK 41.50
FluoGuide
7D
0.2%
1Y
8.1%
CAMX
SEK 554.00
Camurus
7D
-11.1%
1Y
-12.2%
ARJO B
SEK 30.86
Arjo
7D
1.2%
1Y
-13.7%
MCOV B
SEK 236.00
Medicover
7D
-9.4%
1Y
34.5%
ADDV A
SEK 2.48
ADDvise Group
7D
19.2%
1Y
-80.0%
GETI B
SEK 218.30
Getinge
7D
-3.0%
1Y
14.4%
IMP A SDB
SEK 53.40
Implantica
7D
1.5%
1Y
44.3%
EKTA B
SEK 44.90
Elekta
7D
-7.8%
1Y
-31.6%

What Is Elekta AB (publ)'s (STO:EKTA B) Share Price Doing?

Oct 31
What Is Elekta AB (publ)'s (STO:EKTA B) Share Price Doing?
BONEX
SEK 193.90
Bonesupport Holding
7D
-11.5%
1Y
-44.3%

Bonesupport Holding AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

Oct 28
Bonesupport Holding AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
ALIF B
SEK 185.80
AddLife
7D
-9.5%
1Y
35.5%

Optimized Product Portfolio And Acquisitions Will Deliver Future Value

Narrative Update on AddLife: Analyst Price Target Revision Analysts have raised AddLife's fair value estimate from SEK 200 to SEK 213.5, citing incremental improvements in growth and profitability forecasts. Valuation Changes The consensus analyst price target has increased from SEK 200 to SEK 213.5. The discount rate has risen slightly from 5.70% to 5.75%.
BIOA B
SEK 271.60
BioArctic
7D
-6.3%
1Y
79.5%
SECT B
SEK 292.60
Sectra
7D
-4.6%
1Y
3.9%
HAMLET B
SEK 4.20
Hamlet BioPharma
7D
14.3%
1Y
1.4%